10x Genomics Research and Development Expenses 2018-2024 | TXG

10x Genomics research and development expenses from 2018 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
10x Genomics Annual Research and Development Expenses
(Millions of US $)
2023 $270
2022 $266
2021 $212
2020 $123
2019 $83
2018 $48
2017 $32
10x Genomics Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $66
2024-06-30 $63
2024-03-31 $69
2023-12-31 $65
2023-09-30 $67
2023-06-30 $71
2023-03-31 $67
2022-12-31 $64
2022-09-30 $67
2022-06-30 $71
2022-03-31 $64
2021-12-31 $62
2021-09-30 $55
2021-06-30 $53
2021-03-31 $42
2020-12-31 $40
2020-09-30 $30
2020-06-30 $28
2020-03-31 $26
2019-12-31 $28
2019-09-30 $22
2019-06-30 $18
2019-03-31 $15
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.925B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00